If you have started researching weight-loss medication, you have run into the big three names: Ozempic, Wegovy, and Mounjaro. They get used almost interchangeably in conversation, but they are not the same, and the differences matter when you are choosing a medically supervised program. Here is a clear, Calgary-focused breakdown of how they compare.
All three are injectable medications that work on gut hormones, but they are not identical:
So the real comparison is semaglutide versus tirzepatide — with Ozempic and Wegovy being two labels on the same underlying drug.
Semaglutide (Ozempic/Wegovy) activates the GLP-1 receptor, which reduces appetite and slows digestion. Tirzepatide (Mounjaro) activates GLP-1 *and* GIP receptors. In head-to-head research, the dual-action approach has tended to produce greater average weight loss — but "greater on average" does not mean "better for you specifically." Tolerability, side effects, cost, and your health history all factor in.
Here is the part the online comparisons miss: the medication is only one variable. Two people on the exact same drug can get very different results depending on dosing, monitoring, nutrition, and follow-up. That is why our clinic focuses on the complete program rather than just handing out a prescription. The right choice between semaglutide and tirzepatide is made clinically, based on your goals, your tolerance, and what is appropriate and available for you.
You may see cheaper compounded semaglutide or tirzepatide advertised online. These are not the same as the approved branded products, and quality and safety can vary widely. A medically supervised clinic uses appropriate, properly sourced medication and monitors you throughout — which is exactly what these drugs need to be used safely.
Across all three, the most common side effects are gastrointestinal — nausea, and mild digestive changes — usually strongest early and easing with slow dose titration. We cover this in detail in our guide to managing GLP-1 side effects. The takeaway: side effects are manageable, and careful titration is the key, whichever medication you use.
Is Mounjaro always better than Ozempic?
Not necessarily. Tirzepatide has shown greater average weight loss in trials, but the best medication is the one that fits your body, tolerance, and health — a clinical decision, not a headline.
Can I switch between them?
Sometimes, under medical supervision, based on how you respond and tolerate treatment. This is one reason ongoing monitoring matters.
Which one will I be prescribed?
That is determined at your assessment. The goal is the safest, most effective option for you — not a one-size-fits-all answer.
Want a professional to help you choose? Book a consultation with our pharmacist-led team in NW Calgary and get a recommendation based on your health, not a brand name.
Ready to talk to a professional? Book a consultation with our pharmacist-led team to find the right medically supervised approach for you.